Tyche Industries informs about updates

08 Jan 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tyche Industries has informed that, the United States Food & Drug Administration (USFDA) completed inspection of its manufacturing facility situated at Kakinada, Andhra Pradesh during August, 2024 and issued Seven observations. Further informed that United States Food & Drug Administration (USFDA) has classified the inspection as ‘Official Action Indicated’ (OAI). The Company remains committed to work closely with the USFDA and continues to enhance its compliance on an ongoing basis. The company will work with the USFDA to resolve these issues at the earliest. 

The above information is a part of company’s filings submitted to BSE.

Tyche Inds Share Price

113.35 -2.20 (-1.90%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×